ArticleClinicoEconomics and outcomes research : CEOR2017

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK.

Michele R Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.